logo
Select company
Select metric
-231.15%EBITDA Margin
VS
Market
9
Sector
31
Industry
56
History
100
$ 1.75Close
$ 0.36 - $ 2.11 52-Week Range
Ticker Information

Ticker

IVVD

Company Name

INVIVYD INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

INVIVYD INC - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IVVD - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -106.81M-231.15%$ 46.21M
3/31/2025$ -139.39M-379.94%$ 36.69M
12/31/2024$ -166.81M-657.15%$ 25.38M
9/30/2024$ -223.02M-1928.6%$ 11.56M
6/30/2024$ -201.78M-8912.32%$ 2.26M
3/31/2024$ -204.76M0%$ 0
12/31/2023$ -196.62M0%$ 0
9/30/2023$ -167.84M0%$ 0
6/30/2023$ -173.96M0%$ 0
3/31/2023$ -175.09M0%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • INVIVYD INC's latest trailing twelve months (TTM) EBITDA % stands at 0%.
  • Over the past 5 years, INVIVYD INC's average EBITDA % has been -2421.83%.
  • The median EBITDA % for INVIVYD INC during this period was -657.15%
  • INVIVYD INC reached its highest EBITDA % over the past 5 years at -231.15%.
  • The lowest EBITDA % recorded by INVIVYD INC in the same timeframe -8912.32%

INVIVYD INC's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
CELU : CELULARITY INC -130.41%DOMH : DOMINARI HOLDINGS INC -35.03%CSBR : CHAMPIONS ONCOLOGY INC 7.77%SPRO : SPERO THERAPEUTICS INC -110.34%MGX : METAGENOMI INC -236.11%PLX : PROTALIX BIOTHERAPEUTICS INC 17.03%FBIO : FORTRESS BIOTECH INC 10.38%WHWK : WHITEHAWK THERAPEUTICS INC -45.88%ICCC : IMMUCELL CORP 15.8%HYFT : MINDWALK HOLDINGS CORP -123.06%

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for INVIVYD INC is calculated as follows: EBITDA [ $ -148.69M ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ]

IVVD - EBITDA Margin, Last 5 years

-8912.32%

Minimum

Jun 30, 2024

-231.15%

Maximum

Jun 30, 2025

-2421.83%

Average

-657.15%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.89%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-75.07%
max97.73%
average16.12%
median14.72%
std26.89%